Kurzfassung

Pharmacokinetics, safety and tolerability of intravenous Posaconazol solution followed by oral Posaconazol suspension in subjects at high risk for invasive fungal infection.

Projektleitung PD Dr. Andrew Ullmann bis Dezember 2011